Rocket Pharmaceuticals, Inc.
NASDAQRocket Pharmaceuticals heads into its May 11 earnings release carrying one of the heavier short burdens in the small-cap biotech space — and bears built most of that position in the last month alone. Short interest is the defining feature of the current setup. At roughly 17.9% of the free float, the short position is substantial for a stock trading at $3.67. More striking is the…
Snapshot as of 23 Jun 2026
Rocket Pharmaceuticals heads into its May 11 earnings release carrying one of the heavier short burdens in the small-cap biotech space — and bears built most of that position in the last month alone. Short interest is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RCKT — free to start on ORTEX.
Sign up for free →Open RCKT on ORTEX